Tech Company Financing Transactions
BreezeBio Funding Round
BreezeBio secured a $24 million Series A financing round on 1/23/2024. Investors included ACVC Partners, DAYLI Partners and Dong-A ST.
Transaction Overview
Company Name
Announced On
1/23/2024
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Series A
Investors
Eli Lilly and Company (Andrew Adams)
Proceeds Purpose
The funding will support continued development of the NanoGalaxy platform and a pipeline of preclinical therapeutic candidates.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3000 Marina Blvd
Brisbane, CA 94005
USA
Brisbane, CA 94005
USA
Phone
Undisclosed
Website
Email Address
Overview
BreezeBio is a biotechnology company developing precision genetic medicines enabled by targeted, non-viral delivery across biologically relevant tissues. Using our proprietary NanoGalaxy® platform, we engineer nanoparticles designed to deliver genetic payloads, including mRNA, to specific cell types. Our platform has demonstrated delivery to immune cells as well as select tissues in the heart, lung, and central nervous system. We are advancing an internal therapeutic pipeline focused on autoimmune diseases and oncology. Our lead program, BRZ-101, is designed to restore immune tolerance in type 1 diabetes and is advancing into IND-enabling studies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ryan Lee
Chief Financial Officer
Jeff Kang
Chief Operating Officer
Hyo Park
Chief Scientific Officer
J Rodrigo Mora
VP - Bus. Development
Steven Bodovitz
VP - Bus. Development
Dong Kim
VP - Bus. Development
SJ Kim
VP - R & D
Derek Sloan
Browse more venture capital transactions:
Prev: 1/23/2024: Elephas Biosciences venture capital transaction
Next: 1/23/2024: Daytrip venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs